A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
University of Pittsburgh
University of Pittsburgh
University Hospital Augsburg
Case Comprehensive Cancer Center
Philogen S.p.A.
Philogen S.p.A.
Jules Bordet Institute
Helsinki University Central Hospital
VA Office of Research and Development
Centre Hospitalier Universitaire de Nīmes
Association pour la Recherche Clinique et Immunologique